Shenzhen Kangtai Biological Products (, ), also known as BioKangtai (), is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the OxfordâÂÂAstraZeneca COVID-19 vaccine in mainland China.